Barclays Raises Lam Research (LRCX) Price Target to $335 Amid AI-Driven Demand

Barclays maintained its rating on Lam Research Corporation (NASDAQ: LRCX) and raised its price target to $335, according to GuruFocus, citing the chipmaking equipment provider's position at the centre of accelerating artificial intelligence and high-performance computing demand. The revised target arrives as LRCX last traded at $344.88 on Thursday, June 11, up 7.17% on the session, putting the stock above the newly issued Barclays level.

What Changed

• Barclays raised its price target on LRCX to $335, per GuruFocus reporting, while maintaining its existing rating.
• Quarterly revenue has exceeded $5 billion, according to Yahoo Finance, underpinning analyst confidence in near-term demand.
• The Guinness Global Innovators Fund, in its Q1 2026 investor update, highlighted Lam Research as sitting at the heart of the semiconductor value chain, according to Yahoo Finance.
• Wall Street consensus as of June 1, 2026 stands at 10 Strong Buy, 24 Buy, and 8 Hold ratings, with zero Sell or Strong Sell recommendations.
• LRCX has risen 86.8% year-to-date, according to Yahoo Finance, reflecting sustained institutional interest in semiconductor equipment names.

Why It Matters

The Barclays target revision reflects a broader reassessment of semiconductor equipment valuations as AI infrastructure buildouts sustain demand for advanced deposition and etch tools. According to Yahoo Finance, Lam Research's revenue growth is being driven by AI and HPC customers requiring increasingly sophisticated chipmaking processes, a dynamic that has pushed quarterly revenue above $5 billion.

The Guinness Global Innovators Fund's Q1 2026 commentary, as reported by Yahoo Finance, further reinforces the institutional view that Lam occupies a structurally critical position in the chip supply chain. That framing matters for forward estimates: equipment providers that are non-substitutable in leading-edge fab flows carry pricing leverage that supports margin durability over time.

Wall Street View

Analyst consensus as of June 1, 2026 is firmly constructive, with 34 Buy-or-better ratings against 8 Holds and no Sell recommendations, per the data above. Barclays' revised $335 price target, while now below Thursday's trading level, represents an upward revision that signals growing conviction in LRCX's earnings trajectory. The forward P/E of 43.6x (TTM, may not reflect the latest quarter) suggests the market is already pricing in continued revenue and margin expansion.

Investor Takeaway

Barclays' price target increase to $335 and the Guinness Global Innovators Fund's Q1 endorsement together reinforce the institutional consensus that Lam Research's role in enabling advanced semiconductor manufacturing gives it durable revenue visibility. With quarterly revenue above $5 billion and 34 analysts at Buy or better, the fundamental case rests on AI-driven capital expenditure at leading-edge fabs continuing at current levels. Investors will be watching whether sustained demand translates into upward guidance revisions at the next reporting date.